| Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression S Ambs, WG Merriam, WP Bennett, E Felley-Bosco, MO Ogunfusika, ... Cancer Research 58 (2), 334-341, 1998 | 646 | 1998 |
| Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. K Forrester, S Ambs, SE Lupold, RB Kapust, EA Spillare, WC Weinberg, ... Proceedings of the National Academy of Sciences 93 (6), 2442-2447, 1996 | 577 | 1996 |
| Mesothelioma: Scientific clues for prevention, diagnosis, and therapy M Carbone, PS Adusumilli, HR Alexander Jr, P Baas, F Bardelli, A Bononi, ... CA: a cancer journal for clinicians 69 (5), 402-429, 2019 | 480 | 2019 |
| Relationship between p53 mutations and inducible nitric oxide synthase expression in human colorectal cancer S Ambs, WP Bennett, WG Merriam, MO Ogunfusika, SM Oser, ... Journal of the National Cancer Institute 91 (1), 86-88, 1999 | 259 | 1999 |
| Long noncoding RNAs in cancer and therapeutic potential A Renganathan, E Felley-Bosco Long Non Coding RNA Biology, 199-222, 2017 | 246 | 2017 |
| Role of nitric oxide in genotoxicity: implication for carcinogenesis E Felley-Bosco Cancer and Metastasis Reviews 17, 25-37, 1998 | 200 | 1998 |
| Functional inactivation of NF2/merlin in human mesothelioma C Thurneysen, I Opitz, S Kurtz, W Weder, RA Stahel, E Felley-Bosco Lung cancer 64 (2), 140-147, 2009 | 179 | 2009 |
| Caveolin-1 down-regulates inducible nitric oxide synthase via the proteasome pathway in human colon carcinoma cells E Felley-Bosco, FC Bender, F Courjault-Gautier, C Bron, AFG Quest Proceedings of the National Academy of Sciences 97 (26), 14334-14339, 2000 | 176 | 2000 |
| Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin Y Shi, E Felley-Bosco, TM Marti, K Orlowski, M Pruschy, RA Stahel BMC cancer 12, 1-10, 2012 | 144 | 2012 |
| Proteomic analysis of cytokine induced proteins in human intestinal epithelial cells: implications for inflammatory bowel diseases S Barceló‐Batllori, M André, C Servis, N Lévy, O Takikawa, P Michetti, ... Proteomics 2 (5), 551-560, 2002 | 141 | 2002 |
| Functional studies of a germ-line polymorphism at codon 47 within the p53 gene E Felley-Bosco, A Weston, HM Cawley, WP Bennett, CC Harris American journal of human genetics 53 (3), 752, 1993 | 127 | 1993 |
| GAS5 long non-coding RNA in malignant pleural mesothelioma A Renganathan, J Kresoja-Rakic, N Echeverry, G Ziltener, B Vrugt, I Opitz, ... Molecular cancer 13, 1-12, 2014 | 97 | 2014 |
| Dominant negative MyD88 proteins inhibit interleukin-1β/interferon-γ-mediated induction of nuclear factor κB-dependent nitrite production and apoptosis in β cells P Dupraz, S Cottet, F Hamburger, W Dolci, E Felley-Bosco, B Thorens Journal of Biological Chemistry 275 (48), 37672-37678, 2000 | 95 | 2000 |
| Impairment of glucose disposal by infusion of triglycerides in humans: role of glycemia CP Felley, EM Felley, GD van Melle, P Frascarolo, E Jequier, F JP American Journal of Physiology 256, E747-52, 1989 | 91 | 1989 |
| Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin LL Belyanskaya, TM Marti, S Hopkins-Donaldson, S Kurtz, E Felley-Bosco, ... Molecular cancer 6, 1-13, 2007 | 85 | 2007 |
| Medical and surgical care of patients with mesothelioma and their relatives carrying germline BAP1 mutations M Carbone, HI Pass, G Ak, HR Alexander Jr, P Baas, F Baumann, ... Journal of Thoracic Oncology 17 (7), 873-889, 2022 | 84 | 2022 |
| Hippo/YAP pathway for targeted therapy E Felley-Bosco, R Stahel Translational lung cancer research 3 (2), 75, 2014 | 80 | 2014 |
| A novel BRCA1-associated protein-1 isoform affects response of mesothelioma cells to drugs impairing BRCA1-mediated DNA repair R Parrotta, A Okonska, M Ronner, W Weder, R Stahel, L Penengo, ... Journal of Thoracic Oncology 12 (8), 1309-1319, 2017 | 77 | 2017 |
| Role of hedgehog signaling in malignant pleural mesothelioma Y Shi, U Moura, I Opitz, A Soltermann, H Rehrauer, S Thies, W Weder, ... Clinical Cancer Research 18 (17), 4646-4656, 2012 | 72 | 2012 |
| Induction of senescence markers after neo-adjuvant chemotherapy of malignant pleural mesothelioma and association with clinical outcome: an exploratory analysis R Sidi, G Pasello, I Opitz, A Soltermann, M Tutic, H Rehrauer, W Weder, ... European Journal of Cancer 47 (2), 326-332, 2011 | 71 | 2011 |
